Preclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer's Disease
Alzheimer's disease (AD) is a multifactorial, fatal neurodegenerative disorder characterized by the abnormal accumulation of Aβ and Tau deposits in the brain. There is no cure for AD, and failure at different clinical trials emphasizes the need for new treatments. In recent years, significant p...
Saved in:
Main Authors: | Sepideh Parsi (Author), Pascal Y Smith (Author), Claudia Goupil (Author), Véronique Dorval (Author), Sébastien S Hébert (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastrodin ameliorates the lipopolysaccharide-induced neuroinflammation in mice by downregulating miR-107-3p
by: Jin-Jin Song, et al.
Published: (2022) -
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool
by: Vicente Herrero-Aguayo, et al.
Published: (2022) -
Expression pattern of miR-193a, miR122, miR155, miR-15a, and miR146a in peripheral blood mononuclear cells of children with obesity and their relation to some metabolic and inflammatory biomarkers
by: Maryam Behrooz, et al.
Published: (2023) -
circFGFR4 Promotes Differentiation of Myoblasts via Binding miR-107 to Relieve Its Inhibition of Wnt3a
by: Hui Li, et al.
Published: (2018) -
Serum miR-155, miR-21, and CA 15.3 for diagnosis and monitoring therapy of breast cancer in females
by: Khalid O El Khateeb, et al.
Published: (2021)